Neurosurgery. 1992 Jul;31(1):78-82.

Aggressive oligodendroglioma: a chemosensitive tumor.

Source

Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

Abstract

Aggressive oligodendrogliomas, tumors that are symptomatic, enlarging, enhancing, and usually but not always anaplastic, respond to chemotherapy. We have observed responses to chemotherapy in 18 of 19 consecutively treated patients with newly diagnosed or recurrent aggressive oligodendrogliomas. A regimen of procarbazine, CCNU (lomustine), and vincristine (PCV) is predictably effective, but other drugs have antioligodendroglioma activity. Cooperative group trials will be necessary to determine the most effective drug, or combination of drugs, and to explore fully the role of chemotherapy in the treatment of this uncommon glioma.

PMID:: 1641113; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. [J Clin Oncol. 1994]
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C Jr. J Clin Oncol. 1994 Oct; 12(10):2013-21.
[Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma]. [Bull Cancer. 1997]
[Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P. Bull Cancer. 1997 Oct; 84(10):951-6.
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. [Ann Oncol. 2003]
Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.
van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B. Ann Oncol. 2003 Apr; 14(4):599-602.
Review Aggressive oligodendroglioma: a chemosensitive tumor. [Recent Results Cancer Res. 1994]
Review Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG. Recent Results Cancer Res. 1994; 135:127-33.
Review Adults with newly diagnosed high-grade gliomas. [Curr Treat Options Oncol. 2001]
Review Adults with newly diagnosed high-grade gliomas.
Croteau D, Mikkelsen T. Curr Treat Options Oncol. 2001 Dec; 2(6):507-15.

See reviews... See all...

Cited by 4 PubMed Central articles

Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. [Int J Radiat Oncol Biol Phys. ...]
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, et al. Int J Radiat Oncol Biol Phys. 2010 Jul 1; 77(3):662-9. Epub 2009 Sep 23.
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. [Neuro Oncol. 2006]
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.
Hoffman S, Propp JM, McCarthy BJ. Neuro Oncol. 2006 Jan; 8(1):27-37.
Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. [Am J Pathol. 2004]
Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.
Yokoo H, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K, Kamiya M, Sasaki A, Hirato J, Nakazato Y. Am J Pathol. 2004 May; 164(5):1717-25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Aggressive oligodendroglioma: a chemosensitive tumor.
Aggressive oligodendroglioma: a chemosensitive tumor.
Neurosurgery. 1992 Jul ;31(1):78-82.

PubMed
What is the impact of resistance to activated protein C (Leiden mutation to fact...
What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?
Int J Colorectal Dis. 2006 Oct ;21(7):705-10. Epub 2006 Jan 13 .

PubMed
Breast cancer and night work among Norwegian nurses.
Breast cancer and night work among Norwegian nurses.
Cancer Causes Control. 2006 Feb ;17(1):39-44.

PubMed
Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's dis...
Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.
Neurochem Res. 1992 Aug ;17(8):825-9.

PubMed
Cerebellar metastasis as first metastasis from papillary thyroid carcinoma.
Cerebellar metastasis as first metastasis from papillary thyroid carcinoma.
Endocr J. 2005 Dec ;52(6):653-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Aggressive oligodendroglioma: a chemosensitive tumor.

Source

Abstract

Publication Types, MeSH Terms, Substances, Supplementary Concepts

Publication Types

MeSH Terms

Substances

Supplementary Concepts

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information